VIA
CGEN icon

Vident Investment Advisory’s Compugen CGEN Stock Holding History

Vident Investment Advisory’s Portfolio CGEN Stock Details CGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-44,066
Closed -$50.2K – 190
2023
Q2 		$50.2K Buy
44,066
+14,378
+48% +$12.5K ﹤0.01% 1150
2023
Q1 		$20.8K Buy
+29,688
New +$24.4K ﹤0.01% 1223
2020
Q4 		– Sell
-100,258
Closed -$1.63M – 901
2020
Q3 		$1.63M Sell
100,258
-3,342
-3% -$54.8K 0.08% 312
2020
Q2 		$1.56M Buy
+103,600
New +$1.4M 0.08% 299
2017
Q2 		– Sell
-150,614
Closed -$648K – 441
2017
Q1 		$648K Buy
150,614
+25,100
+20% +$116K 0.06% 329
2016
Q4 		$640K Buy
125,514
+22,820
+22% +$137K 0.08% 326
2016
Q3 		$647K Buy
102,694
+22,200
+28% +$150K 0.09% 318
2016
Q2 		$522K Buy
+80,494
New +$537K 0.07% 364

Other funds holding CGEN

TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
Antonetti Capital Management Naples, Florida $64M AUM 3.84% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Vident Investment Advisory's CGEN Position: Q3 2023 in Review

Vident Investment Advisory sold out of Compugen (CGEN) in Q3 2023, closing a stake of 44,066 shares — an estimated $50.2K sold.

Vident Investment Advisory first reported a position in CGEN in Q2 2016 and held it in 8 quarters. The position peaked at $1.63M in Q3 2020. 65 funds tracked by Wall St. Rank hold CGEN as of Q3 2023.

  • Vident Investment Advisory reported no remaining Compugen position as of Q3 2023 after selling out during the quarter.
  • Vident Investment Advisory sold 44,066 Compugen shares in Q3 2023, an estimated $50.2K.
  • Vident Investment Advisory first reported a position in Compugen in Q2 2016 and held it in 8 quarters.
  • Vident Investment Advisory's Compugen position peaked at $1.63M in Q3 2020.
  • 65 funds tracked by Wall St. Rank held Compugen as of Q3 2023.

Based on Vident Investment Advisory's 13F filing for Q3 2023.